{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-119834","form_type":"8-K","ticker":"ELUT","cik":"0001708527","company_name":"ELUTIA INC.","filed_at":"2022-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.786668+00:00","generated_at":"2026-06-21T16:43:37.176039+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Aziyo Q3 revenue $12.4M (+8% YoY); raises FY22 guide; FDA clarity on CanGaroo RM clearance Q1 2023","bullets":["Net sales $12.4M, up 8% YoY; core products $8.9M, non-core $3.4M.","Gross margin 41% (48% ex-intangible amortization) vs 32% prior year due to production efficiencies.","Net loss $9.9M ($0.73/sh) vs $8.3M loss; includes $1.5M litigation expense and $0.8M CEO transition charge.","Cash $8.1M; FY22 revenue guidance raised to $48-50M (prev $47-50M).","Positive FDA meeting; expect CanGaroo RM 510(k) clearance Q1 2023; device compatibility sales +18% YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-119834","json":"https://secwatch.observer/filing/0001104659-22-119834.json","markdown":"https://secwatch.observer/filing/0001104659-22-119834.md","text":"https://secwatch.observer/filing/0001104659-22-119834.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708527/000110465922119834/0001104659-22-119834-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708527/000110465922119834/tm2230834d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T16:43:37.176039+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"880ae24a120a95c0b1271a67d54ca940441d88dc","claim":"ELUTIA INC. reported the full year 2022 results: revenue $48 million to $50 million. Guidance raised.","evidence_excerpt":"Guidance for Full Year 2022 Aziyo updated its expectation that total net sales for the full year 2022 will be in the range of $48 million to $50 million. Excluding approximately $4.9 million of FiberCel sales in 2021, this range represents expected growth of 13% to 18%. This updated guidance compares favorably to the previous guidance range of $47 million to $50 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708527/000110465922119834/0001104659-22-119834-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year 2022"},{"label":"Revenue","value":"$48 million to $50 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"897ccd8a641bac3524e182ac8bea6f2e6bf01493","claim":"ELUTIA INC. reported the quarter ended September 30, 2022 results: revenue $12.4 million, net income $9.9 million, EPS $0.73 per share.","evidence_excerpt":"Net sales for the third quarter of 2022 were $12.4 million, an increase of 8%, compared to the third quarter of 2021. Net sales of core products were $8.9 million in the third quarter of 2022, compared to $8.6 million for the third quarter of 2021, and net sales of non-core products were $3.4 million in the third quarter of 2022, compared to $2.9 million in the third quarter of 2021. Gross profit for the third quarter of 2022 was $5.0 million and gross margin was 41%, as compared to $3.7 million and 32%, respectively, in the corresponding prior-year period. Gross margin, excluding intangible asset amortization (a measure not presented in accordance with U.S. generally accepted accounting principles (\"GAAP\")) was 48% for the third quarter of 2022, as compared to 40% in the third quarter of 2021. The increase in gross margin was primarily due to recent production efficiencies and improved inventory management. 1 Total operating expenses were $12.8 million for the third quarter of 2022, a","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708527/000110465922119834/0001104659-22-119834-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2022"},{"label":"Revenue","value":"$12.4 million"},{"label":"Net income","value":"$9.9 million"},{"label":"EPS","value":"$0.73 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}